China Health Valuation
| CMIM Stock | USD 0.0002 0.00 0.00% |
China Health seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of China Health Care from analyzing the firm fundamentals such as Current Valuation of 9.03 M, price to sales of 0.01 X, and Return On Asset of -0.73 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that China Health's price fluctuation is very steady at this time. Calculation of the real value of China Health Care is based on 3 months time horizon. Increasing China Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the China pink sheet is determined by what a typical buyer is willing to pay for full or partial control of China Health Care. Since China Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of China Pink Sheet. However, China Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.68E-4 | Hype 2.0E-4 |
The intrinsic value of China Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence China Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of China Health Care helps investors to forecast how China pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of China Health more accurately as focusing exclusively on China Health's fundamentals will not take into account other important factors: About China Health Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of China Health Care. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of China Health Care based exclusively on its fundamental and basic technical indicators. By analyzing China Health's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of China Health's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of China Health. We calculate exposure to China Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of China Health's related companies.Changming Industrial Management Group Holding provides hospital management consultancy services to VIP maternity and gynecological centers in China. Changming Industrial Management Group Holding was founded in 2001 and is based in Wan Chai, Hong Kong. Changming Industrial is traded on OTC Exchange in the United States.
8 Steps to conduct China Health's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates China Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct China Health's valuation analysis, follow these 8 steps:- Gather financial information: Obtain China Health's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine China Health's revenue streams: Identify China Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research China Health's industry and market trends, including the size of the market, growth rate, and competition.
- Establish China Health's growth potential: Evaluate China Health's management, business model, and growth potential.
- Determine China Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate China Health's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Other Information on Investing in China Pink Sheet
China Health financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Health security.